Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Jun;14(1):41-43.

A CASE REPORT OF SUSPECTED ANGIOEDEMA IN A CHILD AFTER ADMINISTRATION OF MEBENDAZOLE, COTRIMOXAZOLE AND LEAF EXTRACTS

O F Ashubu  1 , A D Ademola  2 , A O Asinobi  2
Affiliations
Case Reports

A CASE REPORT OF SUSPECTED ANGIOEDEMA IN A CHILD AFTER ADMINISTRATION OF MEBENDAZOLE, COTRIMOXAZOLE AND LEAF EXTRACTS

O F Ashubu et al. Ann Ib Postgrad Med. 2016 Jun.

Abstract

Adverse drug reactions in children are an important public health problem. Children are at a higher risk of developing adverse drug reactions as they seldom express their own drug therapy experiences. Factors that have been implicated include polypharmacy especially with anti-infective and non-steroidal anti-inflammatory drugs; also concomitant use of traditional medicines which is prevalent in some cultures. Cutaneous drug allergy is a common manifestation of adverse drug reactions.

Keywords: Angioedema; Co-trimoxazole; Leaf extracts; Mebendazole.

PubMed Disclaimer

References

    1. World Health Organization. International drug monitoring: the role of national centres. World Health Organ Tech Rep Ser. 1972;498:1–25. - PubMed
    1. Cutaneous drug reaction case reports: from the world literature. Am J Clin Dermatol. 2003;4:511–521. - PubMed
    1. International Development by the Strengthening Pharmaceutical Systems (SPS) Program. Safety of Medicines in Sub-Saharan Africa: Assessment of Pharmacovigilance Systems and their Performance. Arlington, VA:: 2011. Management Sciences for Health. Strengthening Pharmaceutical Systems (SPS) Program.
    1. Oshikoya KA. Adverse drug reactions in children: Types, incidence and risk factors. Nig Journ of Paediatrics. 2006;33:1–7.
    1. Donati M. De medica historia mirabili. Mantuae, per Fr. Osanam. 1586.

Publication types

LinkOut - more resources